Literature DB >> 26226429

Detecting the severity of perinatal anxiety with the Perinatal Anxiety Screening Scale (PASS).

Susanne Somerville1, Shannon L Byrne2, Kellie Dedman3, Rosemary Hagan4, Soledad Coo3, Elizabeth Oxnam3, Dorota Doherty5, Nadia Cunningham6, Andrew C Page6.   

Abstract

BACKGROUND: The Perinatal Anxiety Screening Scale (PASS; Somerville et al., 2014) reliably identifies perinatal women at risk of problematic anxiety when a clinical cut-off score of 26 is used. This study aimed to identify a severity continuum of anxiety symptoms with the PASS to enhance screening, treatment and research for perinatal anxiety.
METHODS: Antenatal and postnatal women (n=410) recruited from the antenatal clinics and mental health services at an obstetric hospital completed the Edinburgh Postnatal Depression Scale (EPDS), the Depression, Anxiety and Stress Scale (DASS-21), the Spielberg State-Trait Anxiety Inventory (STAI), the Beck Depression Inventory II (BDI), and the PASS. The women referred to mental health services were assessed to determine anxiety diagnoses via a diagnostic interview conducted by an experienced mental health professional from the Department of Psychological Medicine - King Edward Memorial Hospital. Three normative groups for the PASS, namely minimal anxiety, mild-moderate anxiety, and severe anxiety, were identified based on the severity of anxiety indicated on the standardised scales and anxiety diagnoses.
RESULTS: Two cut-off points for the normative groups were calculated using the Jacobson-Truax method (Jacobson and Truax, 1991) resulting in three severity ranges: 'minimal anxiety'; 'mild-moderate anxiety'; and 'severe anxiety'. LIMITATIONS: The most frequent diagnoses in the study sample were adjustment disorder, mixed anxiety and depression, generalised anxiety, and post-traumatic stress disorder. This may limit the generalisability of the severity range results to other anxiety diagnoses including obsessive compulsive disorder and specific phobia.
CONCLUSIONS: Severity ranges for the PASS add value to having a clinically validated cut-off score in the detection and monitoring of problematic perinatal anxiety. The PASS can now be used to identify risk of an anxiety disorder and the severity ranges can indicate developing risk for early referrals for further assessments, prioritisation of access to resources and tracking of clinically significant deterioration, improvement or stability in anxiety over time. Crown
Copyright © 2015. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Perinatal; Postnatal; Pregnancy; Screening

Mesh:

Year:  2015        PMID: 26226429     DOI: 10.1016/j.jad.2015.07.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  12 in total

1.  Does maternal somatic anxiety in pregnancy predispose children to hyperactivity?

Authors:  Blanca Bolea-Alamañac; Simon J C Davies; Jonathan Evans; Carol Joinson; Rebecca Pearson; Petros Skapinakis; Alan Emond
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-03-13       Impact factor: 4.785

2.  A qualitative analysis of feelings and experiences associated with perinatal distress during the COVID-19 pandemic.

Authors:  Katie Jones; Virginia Harrison; Michelle L Moulds; Lisa Lazard
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-18       Impact factor: 3.105

3.  Anxiety Disorders Among Women: A Female Lifespan Approach.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Focus (Am Psychiatr Publ)       Date:  2017-04-10

4.  Study protocol for a multisite randomized controlled trial of an internet and mobile-based intervention for preventing and reducing perinatal depressive symptoms.

Authors:  Patricia Kinser; Nancy Jallo; Jennifer Huberty; Evelyn Jones; Leroy Thacker; Sara Moyer; Breanne Laird; Amy Rider; Susan Lanni; Filip Drozd; Silje Haga
Journal:  Res Nurs Health       Date:  2020-12-15       Impact factor: 2.228

5.  Determinants of antenatal depression and postnatal depression in Australia.

Authors:  Felix Akpojene Ogbo; John Eastwood; Alexandra Hendry; Bin Jalaludin; Kingsley E Agho; Bryanne Barnett; Andrew Page
Journal:  BMC Psychiatry       Date:  2018-02-20       Impact factor: 3.630

6.  Validation of the Arabic version of the Perinatal Anxiety Screening Scale (PASS) among antenatal and postnatal women.

Authors:  Hoda Jradi; Thikrayat Alfarhan; Anas Alsuraimi
Journal:  BMC Pregnancy Childbirth       Date:  2020-12-04       Impact factor: 3.007

7.  Perceived social support and prenatal wellbeing; The mediating effects of loneliness and repetitive negative thinking on anxiety and depression during the COVID-19 pandemic.

Authors:  Virginia Harrison; Michelle L Moulds; Katie Jones
Journal:  Women Birth       Date:  2021-01-07       Impact factor: 3.349

8.  Longitudinal changes in wellbeing amongst breastfeeding women in Australia and New Zealand during the COVID-19 pandemic.

Authors:  Vanessa S Sakalidis; Alethea Rea; Sharon L Perrella; Jacki McEachran; Grace Collis; Jennifer Miraudo; Stuart A Prosser; Lisa Y Gibson; Desiree Silva; Donna T Geddes
Journal:  Eur J Pediatr       Date:  2022-08-17       Impact factor: 3.860

9.  Sinhala translation of the Perinatal Anxiety Screening Scale: a valid and reliable tool to detect anxiety disorders among antenatal women.

Authors:  M N Priyadarshanie; M D I A Waas; C S E Goonewardena; A Balasuriya; B C V Senaratna; D M S Fernando
Journal:  BMC Psychiatry       Date:  2020-07-21       Impact factor: 3.630

10.  Wellbeing of Breastfeeding Women in Australia and New Zealand during the COVID-19 Pandemic: A Cross-Sectional Study.

Authors:  Vanessa S Sakalidis; Alethea Rea; Sharon L Perrella; Jacki McEachran; Grace Collis; Jennifer Miraudo; Stuart A Prosser; Lisa Y Gibson; Desiree Silva; Donna T Geddes
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.